Invesco S&P 500 Equal Weight Health Care ETF(RSPH.US)

Company Encyclopedia
View More
name
Invesco S&P 500 Equal Weight Health Care ETF
RSPH.US
News
View More

Revvity Partners with Lilly to Expand Access to AI Drug Discovery Models

Revvity Inc. has partnered with Eli Lilly to enhance access to Lilly's AI drug discovery models via Revvity's Signals platform. This collaboration aims to facilitate AI adoption in biotech by co-funding access for select participants, allowing organizations to use Lilly's models while maintaining data privacy. The initiative supports federated learning, enabling small and midsize biotechs to contribute data and improve AI-driven drug discovery outcomes.

Reuters·
US
LLY
-1.99%
US
RVTY
+2.67%
Reuters·
US
LLY
-1.99%
US
RVTY
+2.67%

Deals of the day-Mergers and acquisitions

On January 9, Aon announced its acquisition of an insurance broker license in Japan and the establishment of a new corporate broking division. Rio Tinto is in preliminary discussions to acquire Glencore, potentially forming the largest mining company with a market value of approximately $207 billion. Additionally, Merck is reportedly negotiating to purchase Revolution Medicines for between $28 billion and $32 billion, according to the Financial Times.

Reuters·
US
RVMD
+10.48%
US
AON
-0.33%
US
MRK
-0.41%
Reuters·
US
RVMD
+10.48%
US
AON
-0.33%
US
MRK
-0.41%

Eli Lilly: TOGETHER-PsA Study Meets Primary Endpoint At 36 Weeks

Eli Lilly and Company (LLY) announced positive topline results from the TOGETHER-PsA Phase 3b trial, which evaluated the use of Taltz and Zepbound in adults with active psoriatic arthritis and obesity. At 36 weeks, 31.7% of patients receiving both treatments achieved a 50% improvement in PsA activity and at least 10% weight reduction, compared to 0.8% on Taltz alone. Detailed results will be presented at a medical meeting, and topline results from the TOGETHER-PsO trial are expected in early 2026.

rttnews·
US
LLY
-1.99%
rttnews·
US
LLY
-1.99%

BUZZ-Health insurers rise after US House advances effort to reinstate healthcare subsidies

Shares of health insurers rose by 1% to 2% after the U.S. House advanced legislation to reinstate expired healthcare subsidies. Elevance Health increased by 2.4%, Centene by 1.4%, Cigna by 1.5%, UnitedHealth by 1.3%, and Molina Healthcare by 1.8%. The legislation aims to lower costs for 24 million Americans under the Affordable Care Act, which is set to expire at the end of 2025. Without congressional action, millions may face higher premiums after COVID-era subsidies expired on December 31. Over the past year, stock performance varied, with significant declines for some insurers.

Reuters·
US
CNC
-0.66%
US
CI
-1.75%
US
UNH
-0.83%
Reuters·
US
CNC
-0.66%
US
CI
-1.75%
US
UNH
-0.83%

SPIE Extends Multi-Technical Maintenance Contract with Merck for Molsheim Site

SPIE SA has extended its multi-technical maintenance contract with Merck for the Molsheim site, expanding the scope to include maintenance of industrial utilities, HVAC systems, and electrical networks. The contract also covers site mobility and building maintenance, including new MOBIUS buildings. SPIE will support Merck in energy efficiency and sustainability initiatives, and has received the 2025 Merck CSR Trophy for its CSR policy and sustainability efforts.

Reuters·
US
MRK
-0.41%
Reuters·
US
MRK
-0.41%
© 2026 Longbridge｜Disclaimer